W1011 Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Silymarin (SM) Following Chronic Dosing in Patients with Chronic Hepatitis C (HCV)

Authors :: Nezam H. Afdhal
Victor Navarro
Michael Fried
Qiang Liu
Roy L. Hawke
Abdus S. Wahed
Josh Berman
Tedi A. Soule
Philip C. Smith
Edward Doo
K. Rajender Reddy
Zhiming Wen
Steven H. Belle
Sarah J. Schrieber
Source :: Gastroenterology. 134:A-831
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Hepatology
Pharmacokinetics
Chronic hepatitis
business.industry
Gastroenterology
Medicine
In patient
Safety tolerability
Dosing
Pharmacology
business
Phase i study

Full Text Access

Tools